|
1
|
Hedinger C, Williams ED and Sobin LH: The
WHO histological classification of thyroid tumors: A commentary on
the second edition. Cancer. 63:908–911. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu T, Xu J, Tian T, Niu F and An CM:
Interpretation of the 2017 US Preventive Services Working Group
Recommendations for Thyroid Cancer Screening. Cancer Res.
45:710–714. 2018.
|
|
3
|
Stewart B and Wild C: World cancer report
2014. International Agency for Research on Cancer. 2014.
|
|
4
|
Kalinichenko VV, Major ML, Wang X,
Petrovic V, Kuechle J, Yoder HM, Dennewitz MB, Shin B, Datta A,
Raychaudhuri P and Costa RH: Foxm1b transcription factor is
essential for development of hepatocellular carcinomas and is
negatively regulated by the p19ARF tumor suppressor. Genes Dev.
18:830–850. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee S, Park YY, Kim SH, Nguyen OT, Yoo YS,
Chan GK, Sun X and Cho H: Human mitochondrial Fis1 links to cell
cycle regulators at G2/M transition. Cell Mol Life Sci. 71:711–725.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang J, Yuan C, Wu J, Elsayed Z and Fu Z:
Polo-like kinase 1-mediated phosphorylation of Forkhead box protein
M1b antagonizes Its SUMOylation and facilitates its mitotic
function. J Biol Chem. 290:3708–3719. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu M, Dai B, Kang SH, Ban K, Huang FJ,
Lang FF, Aldape KD, Xie TX, Pelloski CE, Xie K, et al: FoxM1B is
overexpressed in human glioblastomas and critically regulates the
tumorigenicity of glioma cells. Cancer Res. 66:3593–3602. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cui J, Shi M, Xie D, Wei D, Jia Z, Zheng
S, Gao Y, Huang S and Xie K: FOXM1 promotes the Warburg effect and
pancreatic cancer progression via transactivation of LDHA
expression. Clin Cancer Res. 20:2595–2606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yung MM, Chan DW, Liu VW, Yao KM and Ngan
HY: Activation of AMPK inhibits cervical cancer cell growth through
AKT/FOXO3a/FOXM1 signaling cascade. BMC Cancer. 13:3272013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khongkow P, Gomes AR, Gong C, Man EP,
Tsang JW, Zhao F, Monteiro LJ, Coombes RC, Medema RH, Khoo US and
Lam EW: Paclitaxel targets FOXM1 to regulate KIF20A in mitotic
catastrophe and breast cancer paclitaxel resistance. Oncogene.
35:990–1002. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song IS, Jeong YJ and Han J: Mitochondrial
metabolism in cancer stem cells: A therapeutic target for colon
cancer. BMB Rep. 48:539–540. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin H, Park MH and Kim SM:
3,3′-Diindolylmethane potentiates paclitaxel-induced antitumor
effects on gastric cancer cells through the Akt/FOXM1 signaling
cascade. Oncol Rep. 33:2031–2036. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang X, Qin J and Lu S: Up-regulation of
miR-877 induced by paclitaxel inhibits hepatocellular carcinoma
cell proliferation though targeting FOXM1. Int J Clin Exp Pathol.
8:1515–1524. 2015.PubMed/NCBI
|
|
14
|
Khongkow P, Gomes AR, Gong C, Man EP,
Tsang JW, Zhao F, Monteiro LJ, Coombes RC, Medema RH, Khoo US and
Lam EW: Paclitaxel targets FOXM1 to regulate KIF20A in mitotic
catastrophe and breast cancer paclitaxel resistance. Oncogene.
35:990–1002. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang Y, Liao Y, He H, Xin Q, Tu Z, Kong
S, Cui T, Wang B, Quan S, Li B, et al: FoxM1 Directs STAT3
expression essential for human endometrial stromal decidualization.
Sci Rep. 5:137352015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alvarez-Fernández M and Medema RH: Novel
functions of FoxM1: From molecular mechanisms to cancer therapy.
Front Oncol. 3:302013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen WQ, Zheng RS, Zhang SW, Li N, Zhao P,
Li GL, Wu LY and He J: Report of incidence and mortality in china
cancer registries, 2008. Chin J Cancer Res. 24:171–180. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
McLeod DS, Sawka AM and Cooper DS:
Controversies in primary treatment of low-risk papillary thyroid
cancer. Lancet. 381:1046–1057. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xue S, Wang P, Liu J, Li R, Zhang L and
Chen G: Prophylactic central lymph node dissection in cN0 patients
with papillary thyroid carcinoma: A retrospective study in China.
Asian J Surg. 39:131–136. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yun JS, Lee YS, Jung JJ, Nam KH, Chung WY,
Chang HS and Park CS: The Zuckerkandl's tubercle: A useful
anatomical landmark for detecting both the recurrent laryngeal
nerve and the superior parathyroid during thyroid surgery. Endocr
J. 55:925–930. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tuttle RM, Ball DW, Byrd D, Dilawari RA,
Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel F, et al:
Thyroid carcinoma. J Natl Compr Canc Netw. 8:1228–1274. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dias RC, Marangoni DV, Riley LW and
Moreira BM: Identification of uropathogenic Escherichia coli clonal
group A (CgA) in hospitalised patients. Mem Inst Oswaldo Cruz.
104:787–789. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Laoukili J, Kooistra MR, Brás A, Kauw J,
Kerkhoven RM, Morrison A, Clevers H and Medema RH: FoxM1 is
required for execution of the mitotic programme and chromosome
stability. Nat Cell Biol. 7:126–136. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen H, Zou Y, Yang H, Wang J and Pan H:
Downregulation of FoxM1 inhibits proliferation, invasion and
angiogenesis of HeLa cells in vitro and in vivo. Int
J Oncol. 45:2355–2364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ahmad A, Wang Z, Kong D, Ali S, Li Y,
Banerjee S, Ali R and Sarkar FH: FoxM1 down-regulation leads to
inhibition of proliferation, migration and invasion of breast
cancer cells through the modulation of extra-cellular matrix
degrading factors. Breast Cancer Res Treat. 158:6072016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Millour J, Constantinidou D, Stavropoulou
AV, Wilson MS, Myatt SS, Kwok JM, Sivanandan K, Coombes RC, Medema
RH, Hartman J, et al: FOXM1 is a transcriptional target of ERalpha
and has a critical role in breast cancer endocrine sensitivity and
resistance. Oncogene. 29:2983–2995. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
The MT, Hutchison IL, Costea DE,
Neppelberg E, Liavaag PG, Purdie K, Harwood C, Wan H, Odell EW,
Hackshaw A and Waseem A: Exploiting FOXM1-orchestrated molecular
network for early squamous cell carcinoma diagnosis and prognosis.
Int J Cancer. 132:2095–2106. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yuan H, Min Z and Chen J: Study on the
relationship between the expression of FoxM1 gene and the activity
and invasion of TPC-1 cells in papillary thyroid carcinoma. Chin J
Endocrine Surg. 8:33–37. 2014.
|
